Insights & news

Van Bael & Bellis adds banking, finance and projects team to its transactional services offering

  • 10/01/2022
  • News

In a move that underlines the strategic growth of its transactional services team, international independent law firm Van Bael & Bellis (VBB) is pleased to announce the arrival of leading banking, finance and projects partner Johan Mouraux alongside senior associate Caroline Coppens and associate Lucas De Four.

Based in VBB’s Brussels office, Johan is a seasoned banking, finance and projects partner with two decades of experience who will add strong expertise to the wide range of transactional expertise within the firm.  Johan joins from DLA Piper[1] where he was a partner and head of the Belgium office’s finance, projects and restructuring practice group.  Johan has experience advising all parties involved in financing transactions, including arrangers, lenders, borrowers, investors, sponsors and public authorities.  Johan has particular expertise in the infrastructure sector, renewables, in real estate finance and in leveraged finance.  He also acts on debt restructuring transactions, and advises on financial services regulation in the banking, insurance, and investment services sectors.

Johan has been recognised for many years as a leading practitioner in the main legal directories such as Chambers & Partners, Legal 500 and IFLR 1000, and has received the top accolade of Global Thought Leader in project finance in the International Who’s Who Legal guide. 

Caroline and Lucas also join from DLA Piper.  Together with Johan, the team have built up a leading marketplace reputation.  Client testimonies about the team refer to “a deal-maker firm, which is absolutely primordial for us" and “close, pragmatic, very aware of the environment in which banking operates and very hands-on" (Chambers and Partners 2021), whilst Legal 500 describes the group as “an excellent team of knowledgeable, trustworthy and customer-oriented legal experts”, who are “flexible and take a pro-active approach in getting the deal through” and with “in-depth knowledge of the market”.  

About the Transactional Services Team of VBB

VBB’s transactional services team handles all ranges of complex Belgian and cross-border transactional services.  This includes mergers and acquisitions, capital markets (debt and equity), insolvency and restructuring, private equity and venture capital transactions, as well as corporate real estate transactions.  The transactional services team benefits from the firm’s expertise in other areas, including competition, employment and benefits, dispute resolution and arbitration, general commercial law, intellectual property, GDPR, as well as our sector-specific public law expertise in highly regulated markets (such as renewable energy, telecom, aviation, etc.).  

The team is consistently ranked as one of the leading independent corporate M&A practices in Belgium.

Philippe De Baere, managing partner, comments: “The arrival of Johan and his team is part of our long-standing strategy to be leaders in the specific areas we focus on.  Our transactional services team has gone from strength to strength for well over a decade now and will continue its growth in the future.  Following the opening of our London office, this move shows once again that VBB is a firm that invests in high-end expertise for its clients.

Michel Bonne, head of the transactional services team, adds: “Johan’s team adds strong expertise to our wide range of transactional services, in Belgium and abroad.  We work continuously with Belgian and multinational clients and the finest independent firms around the globe, and Johan’s expertise fits neatly into our strategic goal of being the go-to independent in the market.  We are very excited to work with Johan and his team.

 
[1] Johan joined DLA Piper in 2007 and was made partner in 2012.  He was appointed as head of the finance, projects and restructuring practice group in Belgium in 2017

Attachments:

Key contacts

Related practice areas

Related insights

Sign up for updates
    • 11/01/2022
    • Articles

    Clinical Trials Regulation - Cooperation of Member States in Safety Assessment of Clinical Trials

    The European Commission published yesterday a Commission Implementing Regulation (EU) 2022/20 of 7 January 2022 “laying down rules for the application of Regulation (EU) No 536/2014 of the European Parliament and of the Council as regards setting up the rules and procedures for the cooperation of the Member States in safety assessment of clinical trials” (the Regulation; see, attached copy).

    Read more
    • 10/01/2022
    • Articles

    EFPIA Publishes Regulatory Wish-List Ahead of European Commission Proposals for Pharmaceutical Reform Due in 2022

    As you know, as part of its wide-ranging EU Pharmaceutical Strategy, the European Commission (the Commission) plans to submit proposals for changes to the EU regulatory framework governing medicines later this year. EFPIA, the European Federation of Pharmaceutical Industries and Associations which represents the innovative pharmaceutical sector, anticipated this significant milestone in the rule-making process by publishing a list of recommendations for regulatory modifications (see, attachment).

    Read more
    • 03/01/2022
    • News

    Catherine Longeval appointed Co-Chair of the International Bar Association (IBA)’s Healthcare & Life Sciences Law Committee

    Van Bael & Bellis is pleased to announce that Catherine L. has been appointed Co-Chair of the International Bar Association (IBA) effective January 1st, 2022. This appointment recognizes the high standing of our firm’s thriving life sciences practice in the international life sciences community. Catherine’s Co-Chair during the first year of her two year mandate is Jonás Bergstein of Bergstein Abogados in Uruguay. Together with a dedicated team of fellow Officers, they are committed to further enhancing the visibility and the work of that Committee, which has a dynamic and diverse membership spanning all continents. The Committee focuses on all aspects of healthcare law, pharmaceutical, biotech and medical devices regulatory law, intellectual property, bioethics and scientific developments across the globe. It provides a forum for discussion among health and life science lawyers and aims to provide regular updates of important changes in this field through newsletters, webinars/seminars and conferences. For more information on the work of the IBA’s Healthcare & Life Sciences Law Committee, please click here.

    Read more

Subscribe to our updates

Please select the practice areas you are interested in: *